Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 14.17 USD 3.13% Market Closed
Market Cap: 391.1m USD
Have any thoughts about
ZimVie Inc?
Write Note

ZimVie Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ZimVie Inc
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Z
ZimVie Inc
NASDAQ:ZIMV
Long-Term Debt
$508.8m
CAGR 3-Years
370%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$17.9B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Long-Term Debt
$13.3B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
15%
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$13.1B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ZimVie Inc
Glance View

Market Cap
390.9m USD
Industry
Health Care

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

ZIMV Intrinsic Value
17.8 USD
Undervaluation 20%
Intrinsic Value
Price
Z

See Also

What is ZimVie Inc's Long-Term Debt?
Long-Term Debt
508.8m USD

Based on the financial report for Dec 31, 2023, ZimVie Inc's Long-Term Debt amounts to 508.8m USD.

What is ZimVie Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
370%

Over the last year, the Long-Term Debt growth was -4%. The average annual Long-Term Debt growth rates for ZimVie Inc have been 370% over the past three years .

Back to Top